The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

Disclosure of Conflicts of Interest – Prof. Axel Glasmacher

This is a disclosure report regarding financial/non-financial relationships with for-profit/non-profit healthcare organizations.

Pharmaceutical companies with potential conflict of interest for the period of October-December 2021

Member of Board of Directors:

    • 4D Pharma (chairperson)
    • Active Biotech
    • Ryvu Pharmaceuticals
    • Avencell

Consultancy/other honoraria:

    • Active Biotech
    • Nanexa
    • Cellex GmbH

Stock Ownership (fulfilling the criterion above):

    • 4D Pharma plc
    • Active Biotech
    • Bristol Myers Squibb


Other affiliations with potential conflict of interest

No partnerships to disclose


Last updated on 12 January 2022

Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752
Tel: +32 2 880 62 70